CD8A and COVID-19: To study the properties of SARS-CoV-2-reactive CD8+ T cells in healthy non-exposed individuals (5, 33, 34), we isolated CD8+ T cells responding to SARS-CoV-2 peptide pools from 4 healthy subjects, who provided blood samples pre-COVID-19 pandemic (Fig. 1A and table S1).